全文获取类型
收费全文 | 1116篇 |
免费 | 108篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 23篇 |
妇产科学 | 12篇 |
基础医学 | 172篇 |
口腔科学 | 20篇 |
临床医学 | 156篇 |
内科学 | 204篇 |
皮肤病学 | 28篇 |
神经病学 | 55篇 |
特种医学 | 92篇 |
外科学 | 192篇 |
综合类 | 53篇 |
一般理论 | 1篇 |
预防医学 | 81篇 |
眼科学 | 20篇 |
药学 | 71篇 |
中国医学 | 5篇 |
肿瘤学 | 83篇 |
出版年
2023年 | 10篇 |
2022年 | 16篇 |
2021年 | 45篇 |
2020年 | 32篇 |
2019年 | 22篇 |
2018年 | 40篇 |
2017年 | 27篇 |
2016年 | 32篇 |
2015年 | 27篇 |
2014年 | 34篇 |
2013年 | 51篇 |
2012年 | 62篇 |
2011年 | 67篇 |
2010年 | 46篇 |
2009年 | 41篇 |
2008年 | 57篇 |
2007年 | 100篇 |
2006年 | 46篇 |
2005年 | 68篇 |
2004年 | 34篇 |
2003年 | 32篇 |
2002年 | 38篇 |
2001年 | 22篇 |
2000年 | 32篇 |
1999年 | 20篇 |
1998年 | 17篇 |
1997年 | 15篇 |
1996年 | 13篇 |
1995年 | 9篇 |
1994年 | 17篇 |
1993年 | 26篇 |
1992年 | 24篇 |
1991年 | 29篇 |
1990年 | 12篇 |
1989年 | 12篇 |
1988年 | 16篇 |
1987年 | 10篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 8篇 |
1982年 | 8篇 |
1981年 | 3篇 |
1980年 | 7篇 |
1979年 | 5篇 |
1977年 | 3篇 |
1975年 | 3篇 |
1972年 | 3篇 |
1968年 | 1篇 |
1924年 | 1篇 |
排序方式: 共有1274条查询结果,搜索用时 203 毫秒
1.
2.
3.
LY Chow MRCPsych D Chung MRCPsych V Leung MB BS TF Leung MB ChB CM Leung MRCPsych 《International journal of clinical practice》1997,51(5):330-331
Akathisia as a side-effect of metoclopramide has received increasing attention in consultation-liaison psychiatry in recent years. A case of metoclopramide-induced akathisia resulting in a suicide attempt is reported in order to highlight the suffering of such patients and the factors that lead to misdiagnosis. 相似文献
4.
5.
Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. 总被引:33,自引:0,他引:33
A W Lee Y F Poon W Foo S C Law F K Cheung D K Chan S Y Tung M Thaw J H Ho 《International journal of radiation oncology, biology, physics》1992,23(2):261-270
This is a retrospective analysis of 5037 patients with squamous cell carcinoma of the nasopharynx treated during the years 1976-1985. The stage distribution according to Ho's classification was 9% Stage I, 13% II, 50% III, 22% IV, and 6% Stage V. Only 4488 (89%) patients had a full course of megavoltage radiation therapy. The median equivalent dose to the nasopharyngeal region was 65 Gy and cervical region in node-positive patients 53 Gy. Seventy percent (906/1290) of the node-negative patients had no prophylactic neck irradiation. The overall actuarial 10-year survival rate was 43%, and the corresponding failure-free survival 34%. Altogether, 4157 (83%) patients achieved complete remission lasting more than 6 months, but 53% (2205/4157) of them relapsed after a median interval of 1.4 years. The 10-year actuarial local, regional, and distant failure-free rates were 61%, 64%, and 59%, respectively. Thirty-eight percent (338/891) of all patients with local recurrence achieved second local remission. The local complete remission rate with aggressive re-irradiation alone was 47% (333/706). But 37% (124/338) of the responders recurred the second time. The incidence of distant failure correlated significantly with both the N-stage and the T-stage, with the highest (57%) occurring in patients with N3 disease. The incidence of nodal relapse in node-negative patients was 11% (44/384) among those given prophylactic neck irradiation, but 40% (362/906) among those without. Therapeutic irradiation achieved a complete regional remission rate of 90% (306/339). However, despite successful salvage, these patients had a significantly higher distant failure rate than those without nodal relapse, even if they remained local-failure-free (21% vs 6%). Patients treated during 1981-1985 achieved significantly better treatment results than those treated during 1976-1980, especially in terms of the overall survival (57% vs 47% at 5-year), the overall failure-free survival (42% vs 35% at 5-year), and the local failure-free rate (70% vs 63% at 5-year). The possible contributing factors are discussed. 相似文献
6.
以18-甲基-17β-羟基-17α-乙炔基-雌甾-4-烯-3-酮(18-甲基炔诺酮),17β-羟基-17α-乙缺基-雌甾-4-烯-3-酮(炔诺酮),17β-羟基-17α-乙炔基-雄甾-4-烯-3-酮(妊娠素)和17a-羟基孕甾-4-烯-3,20二酮(17α-羟基黄体酮)为原料,经NaBH,还原、脱水、双键转位和酯化等反应合成一系列3,5-甾二烯化合物,用1HNMR和MS证明了它们的结构。动物筛选结果表明,17β-丙酰氧基-17α-乙炔基-雌甾-3,5-二烯(IVb2有明显的抗早孕活性。中断早期妊娠的作用似与其雌激素活性有关。 相似文献
7.
Chun Yuan Jay S. Tsuruda Kirk N. Beach Cecil E. Hayes Marina S. Ferguson Charles E. Alpers Thomas K. Foo D. Eugene Strandness 《Journal of magnetic resonance imaging : JMRI》1994,4(1):43-49
Atherosclerotic cardiovascular disease is the most common cause of death in the United States. Investigation of atherosclerotic plaque morphology and composition is important because the findings may be useful in predicting prognosis or response to therapy. This study presents high-resolution magnetic resonance (MR) imaging techniques developed on a 1.5-T whole-body imager with a custom-built surface coil, for characterizing the composition and morphology of plaque removed at carotid endarterectomy. The initial comparison of MR imaging and histologic results showed good correlation. In conjunction with MR angiography, these techniques could be used in in vivo imaging to define the size, location, and contents of atherosclerotic plaque at the carotid bifurcation. 相似文献
8.
9.
L I Golbe A N Lieberman M D Muenter J E Ahlskog G Gopinathan A N Neophytides S H Foo R C Duvoisin 《Clinical neuropharmacology》1988,11(1):45-55
Deprenyl, a selective inhibitor of monoamine oxidase, type B, which is free of the "tyramine effect," may ameliorate symptom fluctuations in advanced Parkinson's disease (PD). We randomized 96 patients with marked symptom fluctuations at three centers to receive either deprenyl 5 mg b.i.d. or placebo in parallel fashion in addition to a previously optimized levodopa/carbidopa (Sinemet) regimen. Disability was recorded hourly at home by patients 3 days weekly during the 2-week baseline and the 6-week treatment period. Disability during the "on" state was assessed each week by examination. Mean hourly self-assessment of gait improved in 28 of 50 patients (56%) receiving deprenyl (mean degree of improvement 0.25 points on a 0-2 scale) and in 14 of 46 (30.4%) taking placebo (mean 0.15). Mean hourly overall symptom control improved in 29 (58%) taking deprenyl (mean 0.34) and in 12 (26.1%) taking placebo (mean 0.15) (p less than 0.01 for each parameter). No significant improvement occurred in the objective quality of the "on" state with deprenyl. Mean daily Sinemet dosage decreases were 17% in the deprenyl group and 7% in the placebo group. Adverse effects included nausea, light-headedness, dyskinesias, and hallucinations, all of which abated after the Sinemet dose was reduced. We conclude that deprenyl is of moderate benefit in a majority of patients with symptom fluctuations complicating PD and is generally well tolerated. 相似文献
10.